AsOf

Novo Nordisk · CEOMaziar Mike Doustdar

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2025-08-07
Valid until
still holds
Published
2026-02-04
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · its source page states the value and the date
Confidence
0.95

Sources

“On 7 August 2025, Maziar Mike Doustdar succeeded Lars Fruergaard Jørgensen as president and chief executive officer of Novo Nordisk.”— what the page says, read 2026-11-08

Cite this claim

Each form names the value, its as-of date (2025-08-07), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Novo Nordisk ceo: Maziar Mike Doustdar", as of 2025-08-07. Claim clm_09DBC29C37EF, https://asof.is/claim/clm_09DBC29C37EF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm.
APA
AsOf. (2025). Novo Nordisk ceo: Maziar Mike Doustdar (as of 2025-08-07) [Record clm_09DBC29C37EF]. Retrieved November 9, 2026, from https://asof.is/claim/clm_09DBC29C37EF (source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm)
BibTeX
@misc{asof_clm_09DBC29C37EF,
  author = {AsOf},
  title = {Novo Nordisk ceo: Maziar Mike Doustdar},
  year = {2025},
  howpublished = {\url{https://asof.is/claim/clm_09DBC29C37EF}},
  note = {Claim clm\_09DBC29C37EF, as of 2025-08-07; source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm},
  urldate = {2026-11-09}
}

On the record

/claim/clm_09DBC29C37EF.md/v1/claims/clm_09DBC29C37EFsubmit a correction